长春中医药大学学报2023，Vol.39Issue(12)：1400-1406,7.DOI:10.13463/j.cnki.cczyy.2023.12.021
炎性生物标志物在心力衰竭中的作用及中医药干预研究进展
The role of inflammatory biomarkers in the diagnosis of heart failure and the research progress of traditional Chinese medicine in the prevention and treatment of heart failure
摘要
Abstract
Biomarkers play many positive roles in the prevention and treatment of heart failure(HF),such as prediction,early diagnosis,guidance for treatment,prognosis evaluation,and efficacy evaluation of this disease.Compared with traditional biomarkers of HF[such as brain natriuretic peptide(BNP),high sensitivity troponin Ⅰ protein(hs-TnI),etc.],the role of inflammatory biomarkers in HF is mainly reflected in risk prediction and prognosis evaluation.By carefully combing the research progress of HF inflammatory biomarkers with clinical application prospects in recent years,this paper discusses the intervention role of traditional Chinese medicine targeting inflammatory biomarkers,in order to provide new thinking for the combined application of inflammatory biomarkers and traditional biomarkers in the prevention and treatment of HF,and to provide new ideas for improving the efficacy evaluation of traditional Chinese medicine in the treatment of HF.关键词
心力衰竭/炎性生物标志物/中医药治疗Key words
heart failure/inflammatory biomarkers/traditional Chinese medicine treatment分类
医药卫生引用本文复制引用
张萌,杨戈..炎性生物标志物在心力衰竭中的作用及中医药干预研究进展[J].长春中医药大学学报,2023,39(12):1400-1406,7.基金项目
吉林省中医药科技项目(2023130) （2023130）
